Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

250 Articles

Jon C. Ogg | Oct 13, 2014 at 8:00 AM EDT

Top Analyst Upgrades and Downgrades: Cliffs, CME, Darden, Endo, J.C. Penney and More

These are the top analyst upgrades and downgrades featured by 24/7 Wall St. on Monday, October 13, 2014.

Jon C. Ogg | Oct 7, 2014 at 8:35 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Alcobra, Deere, GT, J.C. Penney and More

These are the top analyst upgrades, downgrades and initiations seen on Tuesday, October 7, 2014.

Lee Jackson | Sep 25, 2014 at 8:35 AM EDT

5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential

For many of the top biotech companies, orphan drugs have morphed into huge winners and have even generated other streams…

Jon C. Ogg | Sep 5, 2014 at 8:10 AM EDT

Top Analyst Upgrades and Downgrades: BP, Ciena, Finisar, SanDisk, VeriFone, Vertex, Wynn and More

These are the top analyst upgrades and downgrades covered by 24/7 Wall St. on Friday, September 5, 2014.

Lee Jackson | Jul 28, 2014 at 8:55 AM EDT

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

ThinkstockA brand new research report from RBC highlights more than 50 biotech event catalysts that are on the horizon. These are…

Lee Jackson | Jul 9, 2014 at 8:40 AM EDT

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit…

Jon C. Ogg | Jul 8, 2014 at 8:10 AM EDT

Top Analyst Upgrades and Downgrades: Abengoa Yield, CSC, Groupon, 3M, Vertex, Williams, Xerox and More

These are the top analyst upgrades, downgrades and initiations from Wall Street firms on Tuesday, July 8, 2014. They include…

Jon C. Ogg | Jun 25, 2014 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Coach, J.C. Penney, Micron, Whole Foods, Vertex and More

These are the top Wall Street analyst upgrades, downgrades and initiations for Wednesday, June 25, 2014. They include Apple, Coach,…

Paul Ausick | Jun 24, 2014 at 1:15 PM EDT

The Real Attraction to Vertex After Cystic Fibrosis Success

Vertex Pharmaceuticals has reported that two Phase 3 studies of its lumacaftor cystic fibrosis drug in combination with its Kalydeco…

Trey Thoelcke | Jun 11, 2014 at 10:15 AM EDT

Upcoming Binary Events Could Lift These Health Care Stocks Much Higher

In a new report, the analysts at health care boutique Leerink highlight numerous upcoming catalysts for some top stocks in…

Jon C. Ogg | Jun 10, 2014 at 8:20 AM EDT

After Idenix: The Next Four Biotech Buyout Candidates

Here are the four top biotech names we found that all have hepatitis C drugs in their current pipelines at…

Jon C. Ogg | May 8, 2014 at 8:35 AM EDT

RBC Doctor Panel Picks in Drugs and Biotech

In a new research report, the pharmaceutical and biotech analysts at RBC highlight their meetings with a group of six…

Trey Thoelcke | Apr 9, 2014 at 8:45 AM EDT

These Top Stocks Are Cheap After Huge Market Sell-Off

ThinkstockIn just a matter of days, the S&P 500 managed to produce a sell-off of more than 6%. The equity…

Trey Thoelcke | Mar 11, 2014 at 8:45 AM EDT

Catalysts That Could Push Top Biotech Stocks Even Higher

Many bears on Wall Street say that biotech stocks are overvalued, but many trade in line with historical valuations. In…

Trey Thoelcke | Jan 29, 2014 at 8:15 AM EST

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

Like many firms on Wall Street, the biotechnology team at UBS thinks that most of the top mega-cap and large…

1 … 9 10 11 12 13 … 17

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

Top Analyst Upgrades and Downgrades: Cliffs, CME, Darden, Endo, J.C. Penney and More

Top Analyst Upgrades and Downgrades: Apple, Alcobra, Deere, GT, J.C. Penney and More

5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential

Top Analyst Upgrades and Downgrades: BP, Ciena, Finisar, SanDisk, VeriFone, Vertex, Wynn and More

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

Top Analyst Upgrades and Downgrades: Abengoa Yield, CSC, Groupon, 3M, Vertex, Williams, Xerox and More

Top Analyst Upgrades and Downgrades: Apple, Coach, J.C. Penney, Micron, Whole Foods, Vertex and More

The Real Attraction to Vertex After Cystic Fibrosis Success

Upcoming Binary Events Could Lift These Health Care Stocks Much Higher

After Idenix: The Next Four Biotech Buyout Candidates

RBC Doctor Panel Picks in Drugs and Biotech

These Top Stocks Are Cheap After Huge Market Sell-Off

Catalysts That Could Push Top Biotech Stocks Even Higher

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

Top Analyst Upgrades and Downgrades: Cliffs, CME, Darden, Endo, J.C. Penney and More

Top Analyst Upgrades and Downgrades: Apple, Alcobra, Deere, GT, J.C. Penney and More

5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential

Top Analyst Upgrades and Downgrades: BP, Ciena, Finisar, SanDisk, VeriFone, Vertex, Wynn and More

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

Top Analyst Upgrades and Downgrades: Abengoa Yield, CSC, Groupon, 3M, Vertex, Williams, Xerox and More

Top Analyst Upgrades and Downgrades: Apple, Coach, J.C. Penney, Micron, Whole Foods, Vertex and More

The Real Attraction to Vertex After Cystic Fibrosis Success

Upcoming Binary Events Could Lift These Health Care Stocks Much Higher

After Idenix: The Next Four Biotech Buyout Candidates

RBC Doctor Panel Picks in Drugs and Biotech

These Top Stocks Are Cheap After Huge Market Sell-Off

Catalysts That Could Push Top Biotech Stocks Even Higher

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do